MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in MoonLake Immunotherapeutics as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +10 vs. Q3 2022
- Shares held
- 37.7M
- +960.7K (+2.6%) vs. Q3 2022
- Total value
- $396.4M
- +$105.5M (+36.3%) vs. Q3 2022
- New holders
- 14
- 6 more added
- Sold out
- 4
- 7 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 76 | $1.00K | 0.00% | +76 | New |
| Bank of America Corp | 7,900 | $83.0K | 0.00% | +7,900 | New |
| Goldman Sachs Group Inc | 10,110 | $106.2K | 0.00% | −100−1.0% | Reduced |
| Geode Capital Management, LLC | 11,451 | $120.0K | 0.00% | +11,451 | New |
| Renaissance Technologies LLC | 11,609 | $122.0K | 0.00% | +11,609 | New |
| Two Sigma Investments, LP | 12,385 | $130.0K | 0.00% | +12,385 | New |
| Virtu Financial LLC | 14,395 | $151.0K | 0.02% | +14,395 | New |
| Meridian Wealth Management, LLC | 15,000 | $154.3K | 0.02% | −12,000−44.4% | Reduced |
| SVB Financial Group | 16,173 | $169.8K | 0.46% | +16,173 | New |
| Morgan Stanley | 27,365 | $287.3K | 0.00% | +24,265+782.7% | Added |
| Cheyne Capital Management (UK) LLP | 32,129 | $337.4K | 0.60% | +32,129 | New |
| JPMorgan Chase & Co | 44,844 | $471.0K | 0.00% | +44,844 | New |
| Barclays PLC | 55,952 | $587.5K | 0.00% | +40,768+268.5% | Added |
| TD Asset Management Inc | 67,312 | $706.8K | 0.00% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 67,654 | $710.4K | 0.01% | +67,654 | New |
| UBS Group AG | 73,388 | $770.6K | 0.00% | −2,276−3.0% | Reduced |
| Acuta Capital Partners, LLC | 93,500 | $981.8K | 0.60% | +93,500 | New |
| Citigroup Inc | 166,317 | $1.75M | 0.00% | +7,230+4.5% | Added |
| FMR LLC | 185,500 | $1.95M | 0.00% | −633,677−77.4% | Reduced |
| Balyasny Asset Management LLC | 217,999 | $2.29M | 0.01% | +118,125+118.3% | Added |
| Tang Capital Management LLC | 245,714 | $2.58M | 0.37% | −13,340−5.1% | Reduced |
| Tekla Capital Management LLC | 300,000 | $3.15M | 0.12% | 00.0% | Unchanged |
| Braidwell LP | 381,120 | $4.00M | 0.13% | +381,120 | New |
| AXA S.A. | 405,284 | $4.26M | 0.02% | +405,284 | New |
| RTW Investments, LP | 500,000 | $5.25M | 0.11% | 00.0% | Unchanged |
| Great Point Partners LLC | 642,566 | $6.75M | 1.39% | +150,566+30.6% | Added |
| BlackRock Inc. | 741,758 | $7.79M | 0.00% | −740.0% | Reduced |
| Price T Rowe Associates Inc | 822,601 | $8.64M | 0.00% | −46,787−5.4% | Reduced |
| Polar Capital Holdings Plc | 876,377 | $9.20M | 0.07% | +876,377 | New |
| TCG Crossover Management, LLC | 1,000,000 | $10.5M | 1.85% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,886,092 | $30.3M | 0.04% | +200,155+7.5% | Added |
| Cormorant Asset Management, LP | 6,065,001 | $63.7M | 4.28% | 00.0% | Unchanged |
| BVF Inc | 21,751,284 | $228.4M | 9.64% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −335,000−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −191,945−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −20,144−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |